This handbook is a collection of linear and non-linear models for fitting experimental data. It
is intended to help researchers fit appropriate curves to their data. Curve fitting, also known …

BACKGROUND: Etanercept is well tolerated and effective in moderate to severe plaque
psoriasis. However, effectiveness and safety data beyond 2.5 years have not been reported. …

Background: Very few studies have addressed the etiology of community-acquired pneumonia
(CAP) treated in an ambulatory setting. Methods: Patients were recruited from physicians’ …

Objective To determine if withdrawing methotrexate (MTX) after 6 months of combination
etanercept (ETN)+MTX, in MTX-inadequate responders with active rheumatoid arthritis (RA), is …

Panitumumab is a fully human monoclonal antibody that targets the epidermal growth factor
receptor. Results from the primary analysis of a phase 3, randomized, controlled study …

Objectives To determine the amount of intravenous immune globulin (IVIG) used across
indications in Canada and which Canadian medical specialties prescribe IVIG. To assess the …

Objective. To evaluate radiographic and clinical outcomes up to 24 months in patients with
RA enrolled in the Canadian Methotrexate and Etanercept Outcome study. Methods. In this …

The health‐related quality of life (HRQOL) claims in the current Epoetin alfa label are based
on the reanalyses of the exercise and physical function data from the Canadian …

Objective. To describe the longterm effectiveness and safety of etanercept in Canadian
patients with psoriatic arthritis (PsA), treated over 24 months in clinical practice. Methods. …

Phase Ib/II oncology trials, despite their small sample sizes, aim to provide information for
optimal internal company decision‐making concerning novel drug development. Hybrid …